TrialClinical and translational science2024

Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitis.

Nabila Ibnou Zekri Lassout et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.